Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of American Battery Technology Company (“American Battery” or “the Company”) (NASDAQ: ABAT). Investors who purchased American Battery securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether American Battery has violated federal securities laws.

Investigation Details

On October 15, 2025, American Battery disclosed in a filing with the U.S. Securities and Exchange Commission that the U.S. Department of Energy (“DoE”) had terminated its grant for the construction of a commercial-scale facility for the manufacturing of battery cathode-grade lithium hydroxide. Under the grant, the DoE would have contributed $57.7 million towards the facility, while the Company would have put in an equal amount. Following this news, American Battery’s stock price fell $6.48 per share, or 57.19%, over the following three trading sessions, closing at $1.85 on October 17, 2025.

What’s Next?

If you are aware of any facts relating to this investigation or purchased American Battery securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660